• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
VCAM-targeting lipid platform brings new hope to the treatment of ischemic stroke.靶向血管细胞黏附分子的脂质平台为缺血性中风的治疗带来了新希望。
Mol Ther. 2024 May 1;32(5):1192-1194. doi: 10.1016/j.ymthe.2024.04.011. Epub 2024 Apr 16.
2
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke.将脂质纳米颗粒靶向血脑屏障以改善急性缺血性中风。
Mol Ther. 2024 May 1;32(5):1344-1358. doi: 10.1016/j.ymthe.2024.03.004. Epub 2024 Mar 7.
3
A novel specific aptamer targets cerebrovascular endothelial cells after ischemic stroke.一种新型特异性适体在缺血性脑卒中后靶向脑血管内皮细胞。
Sci Rep. 2023 Jun 20;13(1):9990. doi: 10.1038/s41598-023-36993-6.
4
Poldip2 controls leukocyte infiltration into the ischemic brain by regulating focal adhesion kinase-mediated VCAM-1 induction.Poldip2 通过调控黏着斑激酶介导的 VCAM-1 诱导来控制白细胞浸润到缺血性脑。
Sci Rep. 2021 Mar 10;11(1):5533. doi: 10.1038/s41598-021-84987-z.
5
Development of endothelial-targeted CD39 as a therapy for ischemic stroke.内皮细胞靶向 CD39 的开发作为缺血性中风的治疗方法。
J Thromb Haemost. 2024 Aug;22(8):2331-2344. doi: 10.1016/j.jtha.2024.04.023. Epub 2024 May 14.
6
Dexmedetomidine compared to low-dose ketamine better protected not only the brain but also the lungs in acute ischemic stroke.右美托咪定与小剂量氯胺酮相比，不仅更好地保护了大脑，而且保护了急性缺血性脑卒中患者的肺部。
Int Immunopharmacol. 2023 Nov;124(Pt B):111004. doi: 10.1016/j.intimp.2023.111004. Epub 2023 Sep 29.
7
Intracranial VCAM1 at time of mechanical thrombectomy predicts ischemic stroke severity.机械取栓时颅内 VCAM1 预测缺血性卒中严重程度。
J Neuroinflammation. 2021 May 11;18(1):109. doi: 10.1186/s12974-021-02157-4.
8
Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: time-course after acute myocardial infarction and stroke.在 PROCELL 研究中急性心血管事件中内皮祖细胞的动员：急性心肌梗死和卒中后的时间进程。
J Mol Cell Cardiol. 2015 Mar;80:146-55. doi: 10.1016/j.yjmcc.2015.01.005. Epub 2015 Jan 22.
9
MAPK: A Key Player in the Development and Progression of Stroke.MAPK：中风发生和发展的关键因素。
CNS Neurol Disord Drug Targets. 2020;19(4):248-256. doi: 10.2174/1871527319666200613223018.
10
Neural Stem Cells for Early Ischemic Stroke.神经干细胞治疗早期缺血性脑卒中。
Int J Mol Sci. 2021 Jul 19;22(14):7703. doi: 10.3390/ijms22147703.

引用本文的文献

1
Celery seed derived reconstituted lipid nanoparticles as an innate neuron-targeted neuroprotective nanomedicine for ischemic stroke treatment.芹菜籽衍生的重构脂质纳米颗粒作为一种用于缺血性中风治疗的天然神经元靶向神经保护纳米药物。
J Nanobiotechnology. 2025 Apr 17;23(1):298. doi: 10.1186/s12951-025-03372-4.

本文引用的文献

1
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke.将脂质纳米颗粒靶向血脑屏障以改善急性缺血性中风。
Mol Ther. 2024 May 1;32(5):1344-1358. doi: 10.1016/j.ymthe.2024.03.004. Epub 2024 Mar 7.
2
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.《心脏病与卒中统计-2022 更新：美国心脏协会报告》。
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
3
Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?急性缺血性脑卒中后 BBB 破坏中的免疫细胞：免疫治疗的靶点？
Front Immunol. 2021 Jun 23;12:678744. doi: 10.3389/fimmu.2021.678744. eCollection 2021.
4
A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity.血脑屏障的结构、功能、损伤及完整性生物标志物概述。
Fluids Barriers CNS. 2020 Nov 18;17(1):69. doi: 10.1186/s12987-020-00230-3.
5
Natural medicine in neuroprotection for ischemic stroke: Challenges and prospective.神经保护缺血性脑卒中的天然药物治疗：挑战与展望。
Pharmacol Ther. 2020 Dec;216:107695. doi: 10.1016/j.pharmthera.2020.107695. Epub 2020 Sep 28.
6
Update of the organoprotective properties of xenon and argon: from bench to beside.氙气和氩气的器官保护特性更新：从实验室到临床应用
Intensive Care Med Exp. 2020 Feb 24;8(1):11. doi: 10.1186/s40635-020-0294-6.
7
Current advances in ischemic stroke research and therapies.目前在缺血性脑卒中研究和治疗方面的进展。
Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165260. doi: 10.1016/j.bbadis.2018.09.012. Epub 2018 Sep 15.
8
Dexmedetomidine pretreatment inhibits cerebral ischemia/reperfusion‑induced neuroinflammation via activation of AMPK.右美托咪定预处理通过激活 AMPK 抑制脑缺血/再灌注诱导的神经炎症。
Mol Med Rep. 2018 Oct;18(4):3957-3964. doi: 10.3892/mmr.2018.9349. Epub 2018 Aug 3.
9
Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis.溶栓药物再灌注治疗 ST 段抬高型心肌梗死患者的疗效和安全性比较：系统评价和网络荟萃分析。
Lancet. 2017 Aug 19;390(10096):747-759. doi: 10.1016/S0140-6736(17)31441-1.
10
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.《2017年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25.

VCAM-targeting lipid platform brings new hope to the treatment of ischemic stroke.

作者信息

Cao Xiang, Li Feifei, Xin Hongliang

机构信息

Department of Pharmacy, Kangda College of Nanjing Medical University, Lianyungang 222000, China; Department of Pharmaceutics, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.

Department of Pharmacy, Kangda College of Nanjing Medical University, Lianyungang 222000, China.

出版信息

Mol Ther. 2024 May 1;32(5):1192-1194. doi: 10.1016/j.ymthe.2024.04.011. Epub 2024 Apr 16.

DOI:10.1016/j.ymthe.2024.04.011
PMID:38631352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11081915/
Abstract
摘要